These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 16378067)
21. Resolution of severe atopic dermatitis after tacrolimus withdrawal. Ponte GM; Baidal DA; Romanelli P; Faradji RN; Poggioli R; Cure P; Froud T; Selvaggi G; Pileggi A; Ricordi C; Alejandro R Cell Transplant; 2007; 16(1):23-30. PubMed ID: 17436852 [TBL] [Abstract][Full Text] [Related]
22. Assessing the effect of immunosuppression on engraftment of pancreatic islets. Vallabhajosyula P; Hirakata A; Shimizu A; Okumi M; Tchipashvili V; Hong H; Yamada K; Sachs DH Transplantation; 2013 Aug; 96(4):372-8. PubMed ID: 23883972 [TBL] [Abstract][Full Text] [Related]
23. Alterations of the female reproductive system in islet recipient receiving immunosuppression. Del Olmo Garcia MI; Lauriola V; Aracena AG; Messinger S; Corrales A; Ricordi C; Alejandro R Cell Transplant; 2011; 20(10):1649-51. PubMed ID: 21396172 [TBL] [Abstract][Full Text] [Related]
24. Protective effect of glucocorticoid-free immunosuppressive regimen in allogenic islet transplantation. Du CY; Xu EK Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):43-7. PubMed ID: 16481281 [TBL] [Abstract][Full Text] [Related]
25. De novo use of sirolimus in immunosuppression regimens in kidney and kidney-pancreas transplantation at the University of California, San Francisco. Vincenti F; Stock P Transplant Proc; 2003 May; 35(3 Suppl):183S-186S. PubMed ID: 12742494 [TBL] [Abstract][Full Text] [Related]
26. Islet of Langerhans allogeneic transplantation at the University of Geneva in the steroid free era in islet after kidney and simultaneous islet-kidney transplantations. Berney T; Bucher P; Mathe Z; Andres A; Bosco D; Mage R; Toso C; Oberholzer J; Becker C; Philippe J; Bühler L; Morel P Transplant Proc; 2004 May; 36(4):1121-2. PubMed ID: 15194390 [TBL] [Abstract][Full Text] [Related]
27. Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts. Jaeger C; Brendel MD; Hering BJ; Eckhard M; Bretzel RG Diabetes; 1997 Nov; 46(11):1907-10. PubMed ID: 9356046 [TBL] [Abstract][Full Text] [Related]
28. Long-term immunosuppression after solitary islet transplantation is associated with preserved C-peptide secretion for more than a decade. Blau JE; Abegg MR; Flegel WA; Zhao X; Harlan DM; Rother KI Am J Transplant; 2015 Nov; 15(11):2995-3001. PubMed ID: 26184712 [TBL] [Abstract][Full Text] [Related]
29. Results of our first nine intraportal islet allografts in type 1, insulin-dependent diabetic patients. Scharp DW; Lacy PE; Santiago JV; McCullough CS; Weide LG; Boyle PJ; Falqui L; Marchetti P; Ricordi C; Gingerich RL Transplantation; 1991 Jan; 51(1):76-85. PubMed ID: 1987709 [TBL] [Abstract][Full Text] [Related]
30. Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade. Posselt AM; Szot GL; Frassetto LA; Masharani U; Tavakol M; Amin R; McElroy J; Ramos MD; Kerlan RK; Fong L; Vincenti F; Bluestone JA; Stock PG Transplantation; 2010 Dec; 90(12):1595-601. PubMed ID: 20978464 [TBL] [Abstract][Full Text] [Related]